Treatment of chronic pain in pediatric rheumatic disease

Area of Science:

• Pediatric Rheumatology
• Pain Management
• Rheumatic Diseases

Background:

• Pain is a prevalent issue in pediatric rheumatic diseases, significantly impacting daily function and quality of life.
• Current treatments, including biologic agents, often fail to fully alleviate pain.
• The multifactorial nature of pain in these children necessitates comprehensive management strategies beyond disease-specific therapies.

Purpose of the Study:

• To review current understanding of pain management in children with rheumatic diseases.
• To highlight the need for a standardized approach to pain assessment and treatment.
• To discuss the role of pharmacologic and non-pharmacologic interventions.

Main Methods:

• Literature review of existing studies and clinical guidelines on pain management in pediatric rheumatic diseases.
• Analysis of common pharmacologic treatments (acetaminophen, NSAIDs, methotrexate, etanercept) and non-pharmacologic interventions (exercise, cognitive-behavioral therapy).
• Consideration of opioid use for refractory pain and avoidance of systemic corticosteroids.

Main Results:

• Pain in pediatric rheumatic diseases is multifactorial and requires a tailored approach.
• Pharmacologic options include analgesics and disease-modifying drugs, while non-pharmacologic methods are crucial.
• Opioids may be necessary for severe, refractory pain, but systemic corticosteroids should be avoided.

Conclusions:

• Effective pain management in children with rheumatic diseases demands a comprehensive, individualized strategy.
• Integration of pharmacologic and non-pharmacologic interventions is key to improving patient outcomes.
• Further research is needed to establish a definitive standard of care for pain management in this population.